NEW YORK (GenomeWeb News) – Active Motif announced Thursday that it has acquired privately held genomics tools maker SwitchGear Genomics for an undisclosed price.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – SwitchGear Genomics today said it has partnered with New England Biolabs to develop a new dual reporter assay system.
Cosmo Bio will distribute the LightSwitch Luciferase Assay System with marketing and technical support from SwitchGear.
BioCat will distribute the firm's LightSwitch Luciferase Assay System in select European countries.
Under the distribution agreement, SwitchGear will offer the reagent as a standalone product as well as part of its own LightSwitch Transfection Optimization kit.
The collaboration brings together SwitchGear's expertise in gene regulatory networks and Sigma-Aldrich's lentiviral technology and is expected to result in a genome-wide collection of target vectors.
The method combines Promega's HaloCHIP DNA-protein complex capture technology and SwitchGear's high-throughput promoter assays.
The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.
The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.
Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.
In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.